Smith & Nephew Spray-On Wound Therapy Misses Leg Ulcer Endpoint
This article was originally published in The Gray Sheet
Executive Summary
A phase III study of the firm's live cell spray-on wound therapy (HP802-247) failed, putting the future of the product, acquired by Smith & Nephew in 2012, in question.